Eldad Elnekave

Eldad Elnekave is a distinguished medical professional currently serving as the Director of the Kahn Center for Interventional Oncology at Shaare Zedek Medical Center in Jerusalem since January 2023. As Co-Founder and CEO of Listen Therapeutics and a member of the 8400 The Health Network since 2018, Eldad has demonstrated a commitment to innovative healthcare solutions. Previously, Eldad held prominent roles at Zebra Medical Vision Ltd as Scientific Chair and Chief Medical Officer, and directed the Clinic of Interventional Oncology at the Davidoff Cancer Institute from 2014 to 2022. Eldad gained valuable experience as an Interventional Radiology Fellow at Memorial Sloan-Kettering Cancer Center and as an HHMI-NIH Research Scholar at the National Institutes of Health. Eldad's educational credentials include an MD from Tufts University School of Medicine, completed in 2006, and a Hart Fellowship at Duke University, where the focus was on documenting communities in stressful transitions.